Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study, Multivessel Percutaneous Treatment During Myocardial Infarction

NCT01160900 is registered in ClinicalTrials.gov with Azienda Ospedaliera San Camillo Forlanini as lead sponsor.

NCT NCT01160900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study, Multivessel Percutaneous Treatment During Myocardial Infarction
Lead sponsor
Azienda Ospedaliera San Camillo Forlanini
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2010
Completion date
July 31, 2012
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, ischemia, myocardial infarction, necrosis, stents